Infectious Diseases

Overview

The groups of this area aim to improve the outcomes of patients with infectious diseases. The Epidemiology and Public Health group focuses on the epidemiology and prevention of healthcare acquired infections, transmissible infections and on the new vaccines. The Infectious Diseases group focuses on improving the strategies of clinical problems observed in clinical practice. The Microbiology group studies the mechanisms of antimicrobial resistance, pathogenicity, genomic epidemiology and infectious diseases diagnostics. The CRIPS group focuses on developing translational and clinical research in critical care, while the SODIR group works in the areas of sepsis, organ dysfunction and resuscitation. There is also a group focused on clinical research on children’s infectious diseases and primary immunodeficiencies. Finally, the CIBBIM-Nanomedicine group Works in the synthesis, characterization and applications of engineered inorganic nanoparticles in the field of infectious diseases.

Publications

260

total

1322

impact factor

5.08

average impact factor

Group Leader: Pere Soler Palacin

team

group-zoom

zoom

group-download

download

Our group has validated the consolidation of its structure and we have incorporated three new people in the research group, one of them thanks to a MINECO grant. We led national and international projects on Zika virus infection in children and gene therapy in primary immunodeficiency. Last 2019, we have participated in 9 clinical trials and 39 research projects. The group has increased the number of publications, resulting in a mean impact factor of 3.68. In addition to previous recognitions, our unit along with Diagnostic Immunology research group have obtained XUEC accreditation from Health Ministry in Immune minority diseases in the area of primary immunodeficiency. Moreover, The PROANEN group has participated in the creation and coordination of a Catalan pediatric PROA group; Vincat PROA Pediatric group. Finally, our close relationship with the patients’ associations and regional foundations brings a central role to patients and their families in conducting responsible research.

34

total

122

impact factor

3^.59

average impact factor

SELECTED ARTICLES

Mensa-Vilaró A, Bravo García-Morato M, de la Calle-Martin O, Franco-Jarava C, Martínez-Saavedra MT, González-Granado LI, González-Roca E, Fuster JL, Alsina L, Mutchinick OM, Balderrama-Rodríguez A, Ramos E, Modesto C, Mesa-Del-Castillo P, Ortego-Centeno N, Clemente D, Souto A, Palmou N, Remesal A, Leslie KS, Gómez de la Fuente E, Yadira Bravo Gallego L, Campistol JM, Dhouib NG, Bejaoui M, Dutra LA, Terreri MT, Mosquera C, González T, Cañellas J, García-Ruiz de Morales JM, Wouters CH, Bosque MT, Cham WT, Jiménez-Treviño S, de Inocencio J, Bloomfield M, Pérez de Diego R, Martínez-Pomar N, Rodríguez-Pena R, González-Santesteban C, Soler-Palacín P, Casals F, Yagüe J, Allende LM, Rodríguez-Gallego JC, Colobran R, Martínez-Martínez L, López-Granados E, Aróstegui JI.
Unexpected Relevant Role of Gene Mosaicism in Patients With Primary Immunodeficiency Diseases.
J Allergy Clin Immunol. 2019 Jan;143(1):359-368.
DOI: 10.1016/j.jaci.2018.09.009.
IF: 14.11
Tesch VK, Abolhassani H, Shadur B, Zobel J, Mareika Y, Sharapova S, Karakoc-Aydiner E, Rivière JG, Garcia-Prat M, Moes N, Haerynck F, Gonzales-Granado LI, Santos Pérez JL, Mukhina A, Shcherbina A, Aghamohammadi A, Hammarström L, Dogu F, Haskologlu S, ?kincio?ullar? AI, Bal SK, Baris S, Kilic SS, Karaca NE, Kutukculer N, Girschick H, Kolios A, Keles S, Uygun V, Stepensky P, Worth A, van Montfrans JM, Peters AMJ, Meyts I, Adeli M, Marzollo A, Padem N, Khojah AM, Chavoshzadeh Z, Stefanija MA, Bakhtiar S, Florkin B, Meeths M, Gamez L, Grimbacher B, Seppänen MR, Lankester A, Gennery AR, Seidel MG. Inborn Errors, Clinical, and Registry Working Parties of the European Society for Blood and Marrow Transplantation (EBMT) and the European Society of Immunodeficiencies (ESID).
Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score. J Allergy Clin Immunol. 2019 Dec.
DOI: 10.1016/j.jaci.2019.12.896.
IF: 14.11
Basile L, Ciruela P, Requena-Méndez A, Vidal MJ, Dopico E, Martín-Nalda A, Sulleiro E, Gascon J, Jané M; The Working Group Of Congenital Chagas Disease In Catalonia. Epidemiology of congenital Chagas disease 6 years after implementation of a public health surveillance system, Catalonia, 2010 to 2015.
Euro Surveill. 2019 Jun;24(26):1900011.
DOI: 10.2807/1560-7917.ES.2019.24.26.19-00011.
IF: 7.42
Rodó C, Suy A, Sulleiro E, Soriano-Arandes A, Maiz N, García-Ruiz I, Arévalo S, Rando A, Anton A, Vázquez Méndez É, Garrido M, Frick A, Rodrigo C, Pumarola T, Carreras E.
Pregnancy outcomes after maternal Zika virus infection in a non-endemic region: prospective cohort study.
Clin Microbiol Infect. 2019 May;25(5):633.e5-633.e9.
DOI: 10.1016/j.cmi.2019.02.008.
IF: 6.43
Henriquez-Camacho C, Serre N, Norman F, Sánchez-Montalvá A, Torrús D, Goikoetxea AJ, Herrero-Martínez JM, Ruiz-Giardín JM, Treviño B, Monge-Maillo B, Molina I, Rodríguez A, García M, López-Vélez R, Pérez-Molina JA; Redivi Study Group.
Clinicoepidemiological characteristics of viral hepatitis in migrants and travellers of the +Redivi network.
Travel Med Infect Dis. 2019 May-Jun;29:51-57.
DOI: 10.1016/j.tmaid.2019.02.001.
IF: 4.87

View all publications